Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus (2020)
- Authors:
- Autor USP: CASTRO JUNIOR, GILBERTO DE - FM
- Unidade: FM
- DOI: 10.1007/s00520-019-05241-x
- Subjects: ESTOMATITE; ESTUDOS RETROSPECTIVOS; ESTUDOS DE COORTES; NEOPLASIAS DE CABEÇA E PESCOÇO; RADIOTERAPIA; TRISMO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Supportive care in cancer
- ISSN: 0941-4355
- Volume/Número/Paginação/Ano: v. 28, n. 9, p. 4345-4352, 2020
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
MORAIS-FARIA, Karina et al. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus. Supportive care in cancer, v. 28, n. 9, p. 4345-4352, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00520-019-05241-x. Acesso em: 15 abr. 2026. -
APA
Morais-Faria, K., Palmier, N. R., Correia, J. de L., Castro Junior, G. de C., Dias, R. B., Pinto, H. da G., et al. (2020). Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus. Supportive care in cancer, 28( 9), 4345-4352. doi:10.1007/s00520-019-05241-x -
NLM
Morais-Faria K, Palmier NR, Correia J de L, Castro Junior G de C, Dias RB, Pinto H da G, Lopes MA, Ribeiro ACP, Brandao TB, Santos-Silva AR. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus [Internet]. Supportive care in cancer. 2020 ; 28( 9): 4345-4352.[citado 2026 abr. 15 ] Available from: https://doi.org/10.1007/s00520-019-05241-x -
Vancouver
Morais-Faria K, Palmier NR, Correia J de L, Castro Junior G de C, Dias RB, Pinto H da G, Lopes MA, Ribeiro ACP, Brandao TB, Santos-Silva AR. Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus [Internet]. Supportive care in cancer. 2020 ; 28( 9): 4345-4352.[citado 2026 abr. 15 ] Available from: https://doi.org/10.1007/s00520-019-05241-x - Non-gastrointestinal stromal tumours soft tissue sarcomas: an update
- Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial
- Epidemiologia do câncer de pulmão
- Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial
- The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer
- Desenvolvimento de fármacos: pesquisa clínica e medicina de precisão
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048
- Real-World molecular testing and treatment patterns in brazilian patients with newly diagnosed locally advanced or metastatic NSCLC
- Health-related quality of life in KEYNOTE-010: a phase II/III study of Pembrolizumab versus Docetaxel in patients with previously treated advanced, programmed death ligand 1-Expressing NSCLC
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
